Works matching IS 01145916 AND DT 2021 AND VI 44 AND IP 7

Results: 8
    1
    2

    A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs.

    Published in:
    Drug Safety, 2021, v. 44, n. 7, p. 743, doi. 10.1007/s40264-021-01070-2
    By:
    • Sarpatwari, Ameet;
    • Mitra-Majumdar, Mayookha;
    • Bykov, Katsiaryna;
    • Avorn, Jerry;
    • Woloshin, Steven;
    • Toyserkani, Gita A.;
    • LaCivita, Cynthia;
    • Manzo, Claudia;
    • Zhou, Esther H.;
    • Pinnow, Ellen;
    • Dal Pan, Gerald J.;
    • Gagne, Joshua J.;
    • Huybrechts, Krista F.;
    • Feldman, William B.;
    • Chin, Kristyn;
    • Kesselheim, Aaron S.
    Publication type:
    Article
    3
    4

    Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference.

    Published in:
    Drug Safety, 2021, v. 44, n. 7, p. 765, doi. 10.1007/s40264-021-01073-z
    By:
    • Cavadino, Alana;
    • Sandberg, Lovisa;
    • Öhman, Inger;
    • Bergvall, Tomas;
    • Star, Kristina;
    • Dolk, Helen;
    • Loane, Maria;
    • Addor, Marie-Claude;
    • Barisic, Ingeborg;
    • Cavero-Carbonell, Clara;
    • Garne, Ester;
    • Gatt, Miriam;
    • Khoshnood, Babak;
    • Klungsøyr, Kari;
    • Latos-Bielenska, Anna;
    • Lelong, Nathalie;
    • Lutke, Reneé;
    • Materna-Kiryluk, Anna;
    • Nelen, Vera;
    • Nevill, Amanda
    Publication type:
    Article
    5
    6
    7
    8